Citadel Advisors
CHTP

Citadel Advisors’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Citadel Advisors’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-100,900
Closed -$557K – 8732
2014
Q1 		$557K Buy
100,900
+77,100
+324% +$387K ﹤0.01% 4207
2013
Q4 		$105K Sell
23,800
-2,400
-9% -$8.11K ﹤0.01% 5570
2013
Q3 		$79K Buy
26,200
+15,900
+154% +$45.7K ﹤0.01% 5513
2013
Q2 		$24K Buy
+10,300
New +$20.8K ﹤0.01% 6001

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Citadel Advisors's CHTP Position: Q2 2014 in Review

Citadel Advisors sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 49,962 shares — an estimated $276K sold.

Citadel Advisors first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $276K in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Citadel Advisors reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Citadel Advisors sold 49,962 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $276K.
  • Citadel Advisors first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • Citadel Advisors's CHELSEA THERAPEUTICS INT'L LTD position peaked at $276K in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Citadel Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.